South Plains Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Sell
15,578
-267
-2% -$31.3K 1.08% 21
2026
Q1
$1.91M Buy
15,845
+310
+2% +$35.8K 1.11% 19
2025
Q4
$1.64M Buy
15,535
+89
+0.6% +$8.36K 0.97% 24
2025
Q3
$1.3M Buy
15,446
+2,485
+19% +$205K 0.81% 32
2025
Q2
$1.03M Buy
12,961
+1,362
+12% +$108K 0.72% 41
2025
Q1
$1.04M Buy
11,599
+1,651
+17% +$154K 0.81% 36
2024
Q4
$990K Buy
+9,948
New +$1.03M 0.76% 39

Other funds holding MRK

South Plains Financial's MRK Position: Q2 2026 in Review

South Plains Financial reduced its Merck (MRK) stake by 1.7% in Q2 2026, selling an estimated $31.3K and leaving 15,578 shares worth $2M. The position accounts for 1.08% of the portfolio, ranked #21.

South Plains Financial first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • South Plains Financial held 15,578 shares of Merck worth $2M as of Q2 2026.
  • South Plains Financial sold 267 Merck shares in Q2 2026, an estimated $31.3K.
  • Merck made up 1.08% of South Plains Financial's portfolio in Q2 2026, its #21 holding.
  • South Plains Financial first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on South Plains Financial's 13F filing for Q2 2026, filed 13 Aug 2026.